Jay McHarg, CEO of AeroSafe Global, discusses the importance of a sustainable, eco-friendly supply chain, how it's critical for pharmaceutical companies and how it can play a role in delivering better outcomes for both patients and the environment.
For more than a year the coronavirus dominated headlines and changed the course of direction for nearly all businesses, regardless of size or focus. As the pandemic started to recede, other pertinent issues reemerged demanding our collective attention. Consider climate change. At the beginning of the pandemic, there was a significant reduction in global greenhouse gases, but that was only a temporary reprieve. As we returned to our old habits, the existential climate change crisis was still awaiting us.
Blue-chip companies are increasingly called upon to demonstrate their commitment to eco-friendly business practices. This is obvious in the automotive industry with manufacturers such as Volvo committing to all-electric vehicles by 2030, and the food industry wherein late 2020, Chipotle launched its own sustainability calculator detailing the environmental impact of every customer order. But these initiatives can be less apparent in other industries.